Cargando…

Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach

It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Okhee, Salman, Sam, von Ungern-Sternberg, Britta S., Lim, Lee Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458362/
https://www.ncbi.nlm.nih.gov/pubmed/37631086
http://dx.doi.org/10.3390/ph16081171
_version_ 1785097148648390656
author Yoo, Okhee
Salman, Sam
von Ungern-Sternberg, Britta S.
Lim, Lee Yong
author_facet Yoo, Okhee
Salman, Sam
von Ungern-Sternberg, Britta S.
Lim, Lee Yong
author_sort Yoo, Okhee
collection PubMed
description It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In this paper, we describe a promising taste-masked flucloxacillin ternary microparticle (FTM) formulation comprising FS, Eudragit EPO (EE), and palmitic acid (PA). To preserve the stability of the thermolabile and readily hydrolysed flucloxacillin, the fabrication process employed a non-aqueous solvent evaporation method at ambient temperature. Optimisation of the fabrication method using a mixture design approach resulted in a robust technique that generated stable and reproducible FTM products. The optimised method utilised only a single solvent evaporation step and minimal amounts of ICH class III solvents. It involved mixing two solution phases—FS dissolved in ethanol:acetone (1:4 v/v), and a combination of EE and PA dissolved in 100% ethanol—to give a ternary FS:EE:PA system in ethanol: acetone (3:1 v/v). Solvent evaporation yielded the FTMs containing an equimolar ratio of FS:EE:PA (1:0.8:0.6 w/w). The fabrication process, after optimisation, demonstrated robustness, reproducibility, and potential scalability.
format Online
Article
Text
id pubmed-10458362
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104583622023-08-27 Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach Yoo, Okhee Salman, Sam von Ungern-Sternberg, Britta S. Lim, Lee Yong Pharmaceuticals (Basel) Article It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In this paper, we describe a promising taste-masked flucloxacillin ternary microparticle (FTM) formulation comprising FS, Eudragit EPO (EE), and palmitic acid (PA). To preserve the stability of the thermolabile and readily hydrolysed flucloxacillin, the fabrication process employed a non-aqueous solvent evaporation method at ambient temperature. Optimisation of the fabrication method using a mixture design approach resulted in a robust technique that generated stable and reproducible FTM products. The optimised method utilised only a single solvent evaporation step and minimal amounts of ICH class III solvents. It involved mixing two solution phases—FS dissolved in ethanol:acetone (1:4 v/v), and a combination of EE and PA dissolved in 100% ethanol—to give a ternary FS:EE:PA system in ethanol: acetone (3:1 v/v). Solvent evaporation yielded the FTMs containing an equimolar ratio of FS:EE:PA (1:0.8:0.6 w/w). The fabrication process, after optimisation, demonstrated robustness, reproducibility, and potential scalability. MDPI 2023-08-17 /pmc/articles/PMC10458362/ /pubmed/37631086 http://dx.doi.org/10.3390/ph16081171 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yoo, Okhee
Salman, Sam
von Ungern-Sternberg, Britta S.
Lim, Lee Yong
Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title_full Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title_fullStr Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title_full_unstemmed Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title_short Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
title_sort taste-masked flucloxacillin powder part 1: optimisation of fabrication process using a mixture design approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458362/
https://www.ncbi.nlm.nih.gov/pubmed/37631086
http://dx.doi.org/10.3390/ph16081171
work_keys_str_mv AT yoookhee tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach
AT salmansam tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach
AT vonungernsternbergbrittas tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach
AT limleeyong tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach